From the Document: " The coronavirus disease (COVID-19) patient surge has contributed to a worldwide shortage of N95 respirators.  WHO [World Health Organization] and CDC [Centers for Disease Control and Prevention] report that airborne transmission of SARSCoV-2 [severe acute respiratory syndrome coronavirus 2] virus may be possible during aerosol-generating procedures (e.g., manual ventilation before intubation, cardiopulmonary resuscitation).  Respirators are used to protect healthcare personnel (HCP) from airborne pathogen exposure; single-use N95 filtering facepiece respirators (FFRs) are the most common type of respirator used in healthcare.  Increased N95 FFR use during the COVID-19 patient surge will likely exceed the available supply, resulting in shortages at many healthcare facilities.  A respirator shortage may lead to HCP exposure to SARSCoV-2 virus during the COVID-19 pandemic"
HIGH PRIORITY- H0577: COVID-19-ECRI Exclusive Hazard Report